The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
There is growing awareness for the need of early diagnostic tools to aid in point-of-care testing in cancer. Tumor biopsy remains the conventional means in which to sample a tumor and often presents with challenges and associated risks. Therefore, alternative sources of tumor biomarkers is needed. L...
Main Authors: | Arutha Kulasinghe, Hanjie Wu, Chamindie Punyadeera, Majid Ebrahimi Warkiani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Micromachines |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-666X/9/8/397 |
Similar Items
-
Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study
by: Juliana Müller Bark, et al.
Published: (2021-06-01) -
Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets
by: Arutha Kulasinghe, et al.
Published: (2019-03-01) -
The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
by: Joanna Kapeleris, et al.
Published: (2018-08-01) -
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
by: Arutha Kulasinghe, et al.
Published: (2019-01-01) -
PD-L1 expressing circulating tumour cells in head and neck cancers
by: Arutha Kulasinghe, et al.
Published: (2017-05-01)